Compare Dover Corp (DOV) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs IDEXX Laboratories, Inc. — how do they compare? Dover Corp trades at $188.83 (market cap $25.45B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Dover Corp pays a 1.11% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 73 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| DOV | IDXX | |
|---|---|---|
Market Cap | $25.45B | $40.43B |
Volume | 661,758 | 692,164 |
Sector | Industrials | Health |
52-Week High | $233.31 | $766.68 |
52-Week Low | $161.16 | $504.70 |
Typical Hold Time | 73 Days | 46 Days |
Enterprise Value | $26.95B | $41.32B |
Dividend Yield | 1.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dover Corporation (DOV) trades at $188.96, showing modest daily gains of 0.36%. The stock maintains strong fundamentals with consistent earnings beats and a 67.86% analyst buy rating. Recent acquisitions and product launches demonstrate growth initiatives, while technical indicators signal near-term bearish pressure with support at $186. The company's 13.48% net margin and 14.98% ROE reflect operational efficiency.
DOV presents a compelling investment case with 28% upside to the $243.20 consensus target. Strong cash flow generation and dividend consistency support shareholder returns, though technical weakness and competitive industrial markets pose near-term risks. The upcoming Q3 2026 earnings report on September 30 will be crucial for confirming growth trajectory.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
